USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
18 Jul 2023 | 02:45 PM GMT

Patients as Consumers: Why Pharma Must Deliver a Convenient, Connected Patient Experience

Anchored by:

Aquil Harjivan
Head of Front-End Innovation
BAYER CONSUMER HEALTH

Participants:

Aquil Harjivan Head of Front-End InnovationBayer Consumer Health
Aquil Harjivan
Head of Front-End InnovationBayer Consumer Health
Jo Peddhinti AdvisoryHLTH Community
Jo Peddhinti
AdvisoryHLTH Community
Anna-Maria Heidinger Head of Digital Innovation HubDaiichi Sankyo Europe
Anna-Maria Heidinger
Head of Digital Innovation HubDaiichi Sankyo Europe
Benjamin Alouf Chief Medical OfficerFloreo
Benjamin Alouf
Chief Medical OfficerFloreo
Brian Flatley VP Consulting Services & US Pharma SolutionsS3 Connected Health
Brian Flatley
VP Consulting Services & US Pharma SolutionsS3 Connected Health
Chandana Fitzgerald President, CommunityHLTH
Chandana Fitzgerald
President, CommunityHLTH
Jamie Campbell Business Development directorAvegen
Jamie Campbell
Business Development directorAvegen
Ken Tubman Head of Patient Engagement ServicesTakeda Cambridge
Ken Tubman
Head of Patient Engagement ServicesTakeda Cambridge
Martin Peters Head International Patient ExperienceNovartis
Martin Peters
Head International Patient ExperienceNovartis
Theo Ahadome Chief Business OfficerWellthy Therapeutics Private Limited
Theo Ahadome
Chief Business OfficerWellthy Therapeutics Private Limited
Ventsislav Dobrev Global Clinical Lead Digital BiomarkersRoche
Ventsislav Dobrev
Global Clinical Lead Digital BiomarkersRoche

About this Meeting

The consumerisation of healthcare has given rise to a new generation of patient with heightened expectations for seamless and personalised experiences. With the continued revolution of digital health, patients are now empowered to actively manage their own health. As we step into this era of consumer-driven healthcare, it becomes imperative for Pharma organisations to adapt and cater to the connected patient. Enhancing patient experiences extends far beyond mere satisfaction and loyalty, it holds the potential to yield improved treatment adherence, better health outcomes, and heightened brand value. In order to meet the needs of this connected patient, Pharma must explore innovative strategies and leverage cutting-edge technologies to bridge the gap between patient expectations and industry capabilities.

Join us in this meeting as we delve into the crucial aspects of the connected patient phenomenon, shedding light on their evolving expectations. We will explore what today's connected patients demand from their healthcare journey and how this shift impacts the pharmaceutical industry. Specifically, we will cover:
- Expectations of the new, connected patient as healthcare is consumerised:
- Why pharma companies are struggling to meet the expectations of the new connected patients.
- The benefits that pharma can gain from delivering a better patient experience, and how to achieve this.